Delivery Order SPE2DB24D8003-SPE2DB25FJTRW
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a Firm Fixed Price pricing type, a ceiling value of $1,665.49, and a period of performance through February 19, 2025. This Delivery Order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
The Defense Logistics Agency (DLA) awarded a $1,730.82 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of Dakota Drug, Inc.'s larger $999,999,999.00 indefinite-delivery contract (SPE2DB24D8001) with the DLA Troop Support Medical's ECAT Generation V Program, which enables the company to provide a wide range of pharmaceutical and...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $3,074.85 firm fixed-price delivery order is for the supply of ZEPBOUND 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of May 16, 2025. Dakota Drug, Inc. also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, that is part of the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,665.96 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products, with a performance period extending to March 26, 2025. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZNH, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,828.26 firm fixed-price delivery order is for the supply of 4567886888 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This federal contract award, valued at $4,606.56, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 4, 2025. Dakota Drug, Inc. specializes in supplying pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, with a focus on supporting U.S. Armed Forces medical operations. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,525.05 firm fixed-price contract is for the delivery of the pharmaceutical product ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML. The contract is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a $999,999,999.00 Indefinite Delivery Contract (IDC) that allows Dakota Drug, Inc. to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The $5,441.71 firm fixed-price contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.0.5ML pharmaceutical products. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of...
This federal contract award, SPE2DB24D8003|SPE2DB25FJTPG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,266.30 firm fixed-price delivery order is for the provision of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is not associated with a set-aside program and has an ultimate completion date of January 6, 2025. Dakota Drug, Inc. is the prime contractor and has a significant single-award...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYYT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota. The $2,994.06 firm fixed-price delivery order is for the provision of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program,...